MATINAS BIOPHARMA HOLDINGS, INC. Restricted Stock or Unit Expense
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Restricted Stock or Unit Expense of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-06-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2014-06-06
- MATINAS BIOPHARMA HOLDINGS, INC. restricted stock or unit expense for the quarter ending 2014-03-31 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. restricted stock or unit expense for the quarter ending 2013-03-31 was $0.00.
| Period end | Restricted Stock or Unit Expense 3 month | Restricted Stock or Unit Expense 32 month |
|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-06-06 | $470.00K 10-Q · filed 2014-06-06 |
| 2013-03-31 | $0.00 10-Q · filed 2014-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |